AHA yesterday commented on recent Medicare Payment Advisory Commission discussions on possible approaches to reducing spending on Part B drugs and biologicals, improving alternative payment models, and revising the hospital wage index. The letter raises concerns with approaches that would shift responsibility for surging drug prices from drug manufacturers to hospitals and patients. Instead, it supports a cap on average sales price inflation that requires drug manufacturers to pay rebates to the federal government when ASP growth exceeds an inflation benchmark, and encourages the commission to further evaluate a payment model that implements mandatory additional rebates to purchasers when the manufacturer’s price increase for a Part B drug exceeds inflation. The letter also raises concerns with possible approaches that would use non-hospital data to calculate the wage index. In addition, AHA voiced support for exploring how a multi-track APM could “provide a glide path to risk for all potential participants” to ensure “a balance between incentivizing participation in models and securing cost savings and high-quality care for patients.” 

Related News Articles

Headline
The U.S. District Court for the District of Rhode Island Sept. 30 denied motions from AbbVie and Novartis seeking a preliminary injunction against the state’s…
Headline
The federal government shut down Oct. 1 following a failed Senate vote on the House-passed continuing resolution to fund the government by midnight Sept. 30.…
Headline
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration’s 340B Rebate Pilot Program far exceed the agency’s…
Headline
The AHA Sept. 29 sent recommendations to the Department of Health and Human Services and the Centers for Medicare & Medicaid Services to help ensure…
Headline
The Centers for Medicare & Medicaid Services announced Sept. 26 that average premiums for Medicare Advantage and Part D would decline slightly in 2026.…
Headline
States have until Sept. 30 to submit an optional letter of intent to the Centers for Medicare & Medicaid Services indicating they plan to apply to the…